Drug Shortage Report for FOQUEST
Report ID | 151791 |
Drug Identification Number | 02470357 |
Brand name | FOQUEST |
Common or Proper name | methylphenidate hydrochloride Controlled Release Capsules |
Company Name | ELVIUM LIFE SCIENCES |
Market Status | MARKETED |
Active Ingredient(s) | METHYLPHENIDATE HYDROCHLORIDE |
Strength(s) | 100MG |
Dosage form(s) | CAPSULE (CONTROLLED RELEASE) |
Route of administration | ORAL ORAL |
Packaging sizes (GTIN)
Click here to see a list of all reports for this drug. |
(See additional packaging sizes) |
Additional packaging sizes | 60 |
ATC code | N06BA |
ATC description | PSYCHOSTIMULANTS AND NOOTROPICS |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | 2022-01-07 |
Actual start date | 2022-01-05 |
Estimated end date | 2024-12-06 |
Actual end date | 2024-11-25 |
Shortage status | Resolved |
Updated date | 2024-11-26 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 3381 STEELES AVENUE EAST TORONTO, ONTARIO CANADA M2H 3S7 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v177 | 2024-11-26 | English | Compare |
v176 | 2024-11-25 | French | Compare |
v175 | 2024-11-25 | English | Compare |
v174 | 2024-11-07 | French | Compare |
v173 | 2024-11-07 | English | Compare |
v172 | 2024-10-29 | French | Compare |
v171 | 2024-10-29 | English | Compare |
v170 | 2024-10-15 | French | Compare |
v169 | 2024-10-15 | English | Compare |
v168 | 2024-09-16 | French | Compare |
v167 | 2024-09-16 | English | Compare |
v166 | 2024-06-24 | French | Compare |
v165 | 2024-06-24 | English | Compare |
v164 | 2024-05-31 | French | Compare |
v163 | 2024-05-31 | English | Compare |
v162 | 2024-05-24 | French | Compare |
v161 | 2024-05-24 | English | Compare |
v160 | 2024-05-13 | French | Compare |
v159 | 2024-05-13 | English | Compare |
v158 | 2024-05-13 | English | Compare |